Blessing Hospital

Quincy, Illinois 62301

2 studies enrolling now · 7 studies all time

What they study most

Atrial Fibrillation, Bladder Cancer, Coronary Artery Disease, Ischemic Stroke; Ischemic Attack, Transient, Lung Cancer, Lung Diseases, Lung Neoplasms, Metastatic Castration-Resistant Prostate Cancer, Metastatic Pancreas Adenocarcinoma, Multiple Pulmonary Nodules, Neoplasms, Neoplasms by Site

Studies at this site

• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) — Running, not enrolling
• Real World Registry for Use of the Ion Endoluminal System — Running, not enrolling
• PROMUS Element Plus US Post-Approval Study — Completed